Literature DB >> 14115690

ONCOLYSIS BY CLOSTRIDIA. V. TRANSPLANTED TUMORS OF THE HAMSTER.

K ENGELBART, D GERICKE.   

Abstract

Entities:  

Keywords:  ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC AGENTS; CLOSTRIDIUM; CYSTADENOCARCINOMA; EXPERIMENTAL LAB STUDY; HAMSTERS; HISTOLOGICAL TECHNICS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MELANOMA; NEOPLASM IMMUNOLOGY; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PATHOLOGY

Mesh：

Substances：

Year:  1964        PMID： 14115690

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  14 in total

Review 1.  Use of preferentially replicating bacteria for the treatment of cancer.

Authors:  M Sznol; S L Lin; D Bermudes; L M Zheng; I King
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Enhancement of incorporation of 131iododeoxyuridine into tumors after application of Clostridium oncolyticum s. butyricum (M 55). Animal experiments on positive scintigraphic localization of tumors.

Authors:  M Volm; D Gerick; J Schuhmacher; K Wayss
Journal:  Eur J Nucl Med       Date:  1977-06-30

3.  [The effect of non-pathogenic Clostridia on malignant tumors].

Authors:  A Propst; J R Möse
Journal:  Z Krebsforsch       Date:  1966

4.  [Significance of the immune resistance for the oncolytic effect of clostridia].

Authors:  K Schweizer
Journal:  Naturwissenschaften       Date:  1971-03

5.  [Tumor therapy with parasites and microorganisms].

Authors:  D Gericke
Journal:  Naturwissenschaften       Date:  1965-12

6.  Bacteriolytic therapy of experimental pancreatic carcinoma.

Authors:  Claudia Maletzki; Michael Gock; Ulrike Klier; Ernst Klar; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

7.  The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene.

Authors:  Zhiyu Li; John Fallon; John Mandeli; James Wetmur; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

8.  A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.

Authors:  Zhiyu Li; John Fallon; John Mandeli; James Wetmur; Savio L C Woo
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

9.  Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Authors:  Shie-Chau Liu; G-One Ahn; Mitomu Kioi; Mary-Jo Dorie; Adam V Patterson; J Martin Brown
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 10.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.